AwardedSpainGoods€15,214,109
suministro de medicamentos exclusivos con principios activos fampridina, natalizumab, nusinersen y peginterferon beta-1a del laboratorio farmacéutico biogen spain s.l. mediante procedimiento negociado por exclusividad sin publicidad.
- Published
- Published 18 July 2025
Overview
suministro de medicamentos exclusivos con principios activos fampridina, natalizumab, nusinersen y peginterferon beta-1a del laboratorio farmacéutico biogen spain s.l. mediante procedimiento negociado por exclusividad sin publicidad.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €15,214,109
- Procedure
- Direct
- Published
- 18 July 2025
Medicinal products for the musculo-skeletal systemAntineoplastic and immunomodulating agentsImmunosuppressive agentsOther nervous system medicinal products
Award outcome
- Awarded value
- €12,241,797
- Award date
- 19 June 2025
- BIOGEN SPAIN S.L
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
18 July 2025
Contracting authority
Servicio Murciano de Salud - Junta de Compras
Procuring entityEspinardo, Spain
ID_PLATAFORMA: 41261690169929
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.